AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Applied Pharmaceutical Innovation receives nearly $22 million from Canada's Life Sciences Fund to launch the Canadian Allied Antimicrobial Supply Resilience project.
Amount Raised
C$22 Million
Round Type
Venture - Series Unknown
CanadaInvestors
Description
Canada's Applied Pharmaceutical Innovation is one of five organizations receiving funding through the federal Life Sciences Fund. The company will utilize the nearly $22 million to support an initiative aimed at securing antibiotic and antimicrobial drugs. This investment is part of a broader effort to enhance Canada's capabilities in life sciences. The project addresses critical public health challenges, including antimicrobial resistance.
Fundz sees it the moment Applied Pharmaceutical Innovation raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
Based on industry dataApplied Pharmaceutical Innovation raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.